BPC-157 is a synthetic peptide investigated in preclinical and animal research for tissue-repair signaling, angiogenesis, and gut-lining studies
PCAC members expressed divergent views but ultimately voted narrowly in favor of adding six peptides BPC-157, KPV, TB-500, MOTs-C, Semax and Epitalon to the list
Legitimate Research Directions: Some peptides DO have potential and are being properly studied: Thymosin Alpha-1: Immune support (approved in 35+ countries, trials in US) BPC-157: IF proper human trials ever happen LL-37: Antimicrobial applications Others: Many peptides have theoretical promise But ONLY if studied properly: Randomized controlled trials Safety studies FDA approval process Medical supervision The Problem: Most "wellness peptides" will NEVER go through this process because: They can't be patented (no profit incentive) Companies would rather sell in gray market Proper trials cost $100M+ If trials show they DON'T work, the market disappears So we're stuck in limbo: promising animal data, zero human data, aggressive marketing
This may include staying hydrated, maintaining a balanced diet, and monitoring for any unusual reactions
The most robust findings emanate from controlled experimental studies, which consistently document EE-induced perturbations in steroidogenesis, gamete quality, and gonadal development across vertebrate species